| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |